Persea is a French biotech start-up developing an MTI: BioTrojan, a game-changing treatment for solid cancers. Their treatment is called BioTrojan in reference to the Trojan horse: it is in short a cellular Trojan horse carrying a suicide gene which, once introduced into the tumor, reacts on contact with the cyclophosphamide acting as the messenger.

Description of the innovative solution:

An advanced therapy medicinal product (ITM) composed of allogeneic mesenchymal stem cells transfected with a suicide gene, which destroys the tumour and vaccinates against tumour recurrence.

–  Biotech

–  Based in Paris

– 2-10 employees

– Created in 2021